Oncology & Hematology Coding Alert

Reader Question:

J3300 and J3301 Both Connect to Kenalog Injection

Question:  How should I report an injection of Kenalog?South Carolina SubscriberAnswer:  Report 96372 (Therapeutic, prophylactic, or diagnostic injection [specify substance or drug]; subcutaneous or intramuscular) for the injection. Then, use J3300 (Injection, triamcinolone acetonide, preservative free, 1 mg) or J3301 (Injection, triamcinolone acetonide, not otherwise specified, 10 mg) for the Kenalog itself. Pay careful attention to the code descriptors when reporting units. For J3300, you should report 1 unit per 1 mg. In contrast, you should report 1 unit per 10 mg for J3301.Physicians may order injections of this corticosteroid for patients with certain hematologic disorders (acquired hemolytic anemia, Diamond-Blackfan anemia, pure red cell aplasia, and certain cases of secondary thrombocytopenia), as well as a variety of other conditions, including hypercalcemia associated with cancer.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All